
Why VC-Backed Longevity Startups Are Dying In A $5 Trillion Wellness Market
Venture Capital
Why It Matters:Consumer interest in longevity and wellness has never been higher—with the global…
Venture Capital
Why It Matters:Consumer interest in longevity and wellness has never been higher—with the global…
Venture Capital
For decades, radiology was the dream. One of the coveted R.O.A.D. specialties—Radiology, Ophthalmology, Anesthesiology,…
Venture Capital
As agentic AI begins to drive online discovery and decisions, Cimulate’s cofounders—an MIT professor…
Venture Capital
Why It Matters Define Ventures’ new report provides a clear framework for how enterprise…
Venture Capital
As ransomware, regulation, and geopolitical instability strain traditional cloud systems, Finland’s SpaceTime is rethinking…
Venture Capital
Flush with funding and surging demand, compounding pharmacies are attracting capital from private equity…
Venture Capital
As demand surges for semaglutide alternatives like compounded GLP-1 medications, telehealth platforms, compounding pharmacies,…
Venture Capital
The next breakthrough in cancer screening is emerging from the convergence of artificial intelligence…
Venture Capital
Despite billions in tech upgrades, fashion e-commerce is still cluttered, impersonal, and wasteful—especially in…
Venture Capital
From underdiagnosed dense breast tissue to the risk of recurrence, breakthroughs—from DeepLook Medical’s imaging…